Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Treatments of Migraine with Triptans in Individuals with Elevated Cardiovascular Risk and in Pregnant Women

NCT05854992 is registered in ClinicalTrials.gov with Mayo Clinic as lead sponsor.

NCT NCT05854992
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05854992 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Treatments of Migraine with Triptans in Individuals with Elevated Cardiovascular Risk and in Pregnant Women
Lead sponsor
Mayo Clinic
Phase
Observational
Overall status
Completed
Start date
July 5, 2022
Completion date
November 1, 2024
Enrollment
68,419 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

cardiovascular diseases, migraine, pregnancy